Inside informationEnglish
OSE Immunotherapeutics Appoints Dr. Sonya Montgomery as Chief Development Officer
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Ose Immunotherapeutics
- Filed
- 13/01/2025, 18:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 112899_20250113